These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4038840)

  • 1. Treatment of advanced endometrial carcinoma with cisplatin, cyclophosphamide and doxorubicin.
    Deppe G; Lin Liu T
    Acta Obstet Gynecol Scand; 1985; 64(1):83-4. PubMed ID: 4038840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of cisplatin, doxorubicin, and cyclophosphamide to treat advanced and recurrent adenocarcinoma of the endometrium.
    Hancock KC; Freedman RS; Edwards CL; Rutledge FN
    Cancer Treat Rep; 1986 Jun; 70(6):789-91. PubMed ID: 3731140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced or recurrent adenocarcinoma of the endometrium with doxorubicin and cyclophosphamide.
    Campora E; Vidali A; Mammoliti S; Ragni N; Conte PF
    Eur J Gynaecol Oncol; 1990; 11(3):181-3. PubMed ID: 2209636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced endometrial carcinoma.
    Turbow MM; Ballon SC; Sikic BI; Koretz MM
    Cancer Treat Rep; 1985 May; 69(5):465-7. PubMed ID: 4039978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
    Burke TW; Stringer CA; Morris M; Freedman RS; Gershenson DM; Kavanagh JJ; Edwards CL
    Gynecol Oncol; 1991 Mar; 40(3):264-7. PubMed ID: 2013451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin and cyclophosphamide chemotherapy for disseminated endometrial cancer.
    Seski JC; Edwards CL; Gershenson DM; Copeland LJ
    Obstet Gynecol; 1981 Jul; 58(1):88-91. PubMed ID: 7195533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide, doxorubicin, and cisplatin in advanced salivary gland cancer.
    Debaere D; Vander Poorten V; Nuyts S; Hauben E; Schoenaers J; Schöffski P; Clement PM
    B-ENT; 2011; 7(1):1-6. PubMed ID: 21563549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of recurrent endometrial adenocarcinoma with a combination of doxorubicin and cisplatin.
    Tropé C; Johnsson JE; Simonsen E; Christiansen H; Cavallin-Ståhl E; Horváth G
    Am J Obstet Gynecol; 1984 Jun; 149(4):379-81. PubMed ID: 6539567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination chemotherapy using cyclophosphamide, adriamycin, and cisplatin in recurrent or advanced endometrial cancer--a preliminary report].
    Baba S; Kashimura M; Shinohara M; Kusano S; Sasayama T; Hamasaki K
    Gan No Rinsho; 1989 Feb; 35(3):371-7. PubMed ID: 2926985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current role of chemotherapy in the treatment of adenocarcinomas of the endometrium].
    Chauvergne J; Avril A; Pigneux J; Mage P; Granger C
    Bull Cancer; 1986; 73(6):675-9. PubMed ID: 3105628
    [No Abstract]   [Full Text] [Related]  

  • 11. Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens.
    Pasmantier MW; Coleman M; Silver RT; Ballard WP
    Cancer Treat Rep; 1985 Jun; 69(6):689-93. PubMed ID: 3926310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of recurrent and metastatic endometrial cancer with cisplatin, doxorubicin, cyclophosphamide, and megestrol acetate.
    Hoffman MS; Roberts WS; Cavanagh D; Praphat H; Solomon P; Lyman GH
    Gynecol Oncol; 1989 Oct; 35(1):75-7. PubMed ID: 2477317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin-cyclophosphamide: effective chemotherapy for advanced endometrial adenocarcinoma.
    Muggia FM; Chia G; Reed LJ; Romney SL
    Am J Obstet Gynecol; 1977 Jun; 128(3):314-9. PubMed ID: 860739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy of advanced endometrial adenocarcinoma with adriamycin, cyclophosphamide, 5-fluorouracil, and medroxyprogesterone acetate.
    Bruckner HW; Deppe G
    Obstet Gynecol; 1977 Jul; 50(1 Suppl):10s-12s. PubMed ID: 876531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of advanced endometrial carcinoma with doxorubicin and cisplatin: effects on both untreated and previously treated patients.
    Pasmantier MW; Coleman M; Silver RT; Mamaril AP; Quiguyan CC; Galindo A
    Cancer Treat Rep; 1985 May; 69(5):539-42. PubMed ID: 4039980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of adriamycin with cyclophosphamide in patients with advanced endometrial cancer.
    Horton J; Begg CB; Arseneault J; Bruckner H; Creech R; Hahn RG
    Cancer Treat Rep; 1978 Jan; 62(1):159-61. PubMed ID: 626996
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.
    Krook JE; Fleming TR; Eagan RT; Cullinan S; Pfeifle D; Elliott T; Etzell P
    Cancer Treat Rep; 1984 Mar; 68(3):493-8. PubMed ID: 6322987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine papillary serous carcinoma. Complete response to combination chemotherapy.
    Fitzgerald D; Rosenthal S
    Cancer; 1985 Sep; 56(5):1023-4. PubMed ID: 4040419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinoma.
    Edmonson JH; Krook JE; Hilton JF; Malkasian GD; Everson LK; Jefferies JA; Mailliard JA
    Gynecol Oncol; 1987 Sep; 28(1):20-4. PubMed ID: 3653766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
    Barlow JJ; Lele SB
    Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.